SouthState’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
SouthState's AXSM Position: Q3 2026 in Review
SouthState sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 2 shares — an estimated $490 sold.
SouthState first reported a position in AXSM in Q2 2026 and held it in 1 quarter. The position peaked at $490 in Q2 2026. 348 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- SouthState reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
- SouthState sold 2 Axsome Therapeutics shares in Q3 2026, an estimated $490.
- SouthState first reported a position in Axsome Therapeutics in Q2 2026 and held it in 1 quarter.
- SouthState's Axsome Therapeutics position peaked at $490 in Q2 2026.
- 348 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.